|
|
|
|
| LEADER |
02011nmm a2200313 u 4500 |
| 001 |
EB000897669 |
| 003 |
EBX01000000000000000694789 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
141008 ||| eng |
| 020 |
|
|
|a 9781493903986
|
| 100 |
1 |
|
|a Ferran, Christiane
|e [editor]
|
| 245 |
0 |
0 |
|a The Multiple Therapeutic Targets of A20
|h Elektronische Ressource
|c edited by Christiane Ferran
|
| 250 |
|
|
|a 1st ed. 2014
|
| 260 |
|
|
|a New York, NY
|b Springer New York
|c 2014, 2014
|
| 300 |
|
|
|a XXI, 188 p. 48 illus., 2 illus. in color
|b online resource
|
| 505 |
0 |
|
|a A20—A Bipartite Ubiquitin Editing Enzyme with Immunoregulatory Potential -- The Biology of A20-Binding Inhibitors of NF- κB Activation (Abins) -- The Biology of A20-Like Molecules -- Anti-Viral Tetris: Modulation of the Innate Anti-Viral Immune Response by A20 -- A20 Expressing Tumors and Anticancer Drug Resistance -- Translational Studies of A20 in Atherosclerosis and Cardiovascular Disease -- A Biomarker of Allograft Outcome: A Showcase in Kidney Transplantation -- A20—An Omnipotent Protein in the Liver: Prometheus Myth Resolved? -- Emerging Roles for A20 in Islet Biology and Pathology -- Single Nucleotide Polymorphisms at the TNFAIP3/A20 Locus and Susceptibility/Resistance to Inflammatory and Autoimmune Diseases
|
| 653 |
|
|
|a Medical sciences
|
| 653 |
|
|
|a Human Physiology
|
| 653 |
|
|
|a Human physiology
|
| 653 |
|
|
|a Health Sciences
|
| 653 |
|
|
|a Biochemistry
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 490 |
0 |
|
|a Advances in Experimental Medicine and Biology
|
| 028 |
5 |
0 |
|a 10.1007/978-1-4939-0398-6
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4939-0398-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 612
|
| 520 |
|
|
|a This book is meant to provide the most current knowledge regarding the mechanisms of action of A20, if its versatile functions and their validation in animal models of human disease and its promise as a diagnostic biomarker and therapeutic target
|